TROMBETTA, CLAUDIA MARIA
 Distribuzione geografica
Continente #
EU - Europa 5.338
NA - Nord America 3.422
AS - Asia 618
AF - Africa 43
SA - Sud America 10
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.436
Nazione #
US - Stati Uniti d'America 3.407
GB - Regno Unito 2.858
IT - Italia 688
IE - Irlanda 674
RU - Federazione Russa 321
CN - Cina 274
SE - Svezia 241
SG - Singapore 184
UA - Ucraina 165
FR - Francia 143
VN - Vietnam 114
DE - Germania 93
FI - Finlandia 66
CI - Costa d'Avorio 36
BE - Belgio 21
ES - Italia 18
TR - Turchia 17
CA - Canada 13
IN - India 13
NL - Olanda 11
CZ - Repubblica Ceca 7
AT - Austria 4
CH - Svizzera 4
IR - Iran 4
LT - Lituania 4
NG - Nigeria 4
BR - Brasile 3
HK - Hong Kong 3
HU - Ungheria 3
PH - Filippine 3
AU - Australia 2
BG - Bulgaria 2
DK - Danimarca 2
EC - Ecuador 2
EU - Europa 2
KG - Kirghizistan 2
PE - Perù 2
RO - Romania 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
RS - Serbia 1
TJ - Tagikistan 1
ZA - Sudafrica 1
Totale 9.436
Città #
Southend 2.802
Dublin 667
Fairfield 452
Santa Clara 388
Chandler 354
Siena 269
Woodbridge 236
Ashburn 232
Seattle 195
Houston 185
Wilmington 162
Ann Arbor 155
Singapore 145
Jacksonville 138
Cambridge 131
Dong Ket 113
Princeton 87
Beijing 59
San Diego 46
Nanjing 42
Rome 40
San Mateo 39
Florence 37
Abidjan 36
Helsinki 33
Boardman 31
Shanghai 30
Munich 25
Dearborn 24
Moscow 24
New York 23
Brussels 20
Lappeenranta 20
Milan 20
Málaga 17
Nanchang 16
Livorno 15
Shenyang 14
Redwood City 13
Izmir 11
Toronto 11
Fremont 10
Kunming 10
London 10
Hebei 8
Jinan 8
Roccagorga 8
Tianjin 8
Zhengzhou 8
Frankfurt am Main 7
Guangzhou 7
Bari 6
Los Angeles 6
Norwalk 6
San Francisco 6
Bologna 5
Chicago 5
Dallas 5
Phoenix 5
Washington 5
Abuja 4
Brescia 4
Brno 4
Carmignano 4
Fuzhou 4
Haikou 4
Jiaxing 4
Naples 4
Newark 4
Teramo 4
Venezia 4
Vienna 4
Amsterdam 3
Andover 3
Arezzo 3
Gattatico 3
Greenwich 3
Groningen 3
Hangzhou 3
Hounslow 3
Leawood 3
Mersin 3
Ningbo 3
Olomouc 3
Padova 3
Perugia 3
Pisa 3
Pontedera 3
Ryazan 3
St Petersburg 3
Taizhou 3
Torre Del Greco 3
Zurich 3
Alba 2
Aversa 2
Bangalore 2
Bellegra 2
Bibbiena 2
Bishkek 2
Briey 2
Totale 7.615
Nome #
"OKKIO alla salute 2014" results from the Tuscan sample 532
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 474
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions 462
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 407
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy 399
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy 356
Egg-Independent Influenza Vaccines and Vaccine Candidates 223
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 217
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children 194
Influenza anti-stalk antibodies: Development of a new method for the evaluation of the immune responses to universal vaccine 190
Influenza immunology evaluation and correlates of protection: a focus on vaccines 189
Emerging influenza strains in the last two decades: A threat of a new pandemic? 176
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 174
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 169
Challenges in the development of egg-independent vaccines for influenza 161
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses 157
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production 156
Retrospective Study Evaluating Seroprevalence of Hepatitis E Virus in Blood Donors and in Swine Veterinarians in Italy (2004) 153
Impact of erythrocyte species on assays for influenza serology 150
Influenza vaccines: Evaluation of the safety profile 149
Solubilization methods and reference 2-DE map of cow milk fat globules 148
null 136
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 135
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 134
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 132
Measles in pregnancy: a threat for Italian women? 130
Is influenza A/H10N8 a potential candidate for the next pandemic? 127
Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses 125
Elettroforesi bidimensionale 124
Overview of serological techniques for influenza vaccine evaluation: Past, Present and Future 123
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 120
null 116
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples 115
Expression of sialic acid influenza receptors in red blood cells from avian and mammalian species: an immunological comparative study 114
Immunity to measles in Italian children and adolescents: a persistent problem in view of measles elimination 113
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains 109
Low prevalence of antibodies against pertussis in pregnant women in Italy 108
Water and air ozone treatment as an alternative sanitizing technology 106
Medicine use and recurrent complaints among 15-years-old adolescents in Tuscany 106
Zika virus in west africa: A seroepidemiological study between 2007 and 2012 101
Immunoproteomics of myasthenia 95
Evaluation of maternal perception of children's weight and body mass index in tuscany, Italy 92
Evaluating influenza vaccines: Progress and perspectives 91
Evaluation of varicella immunity during pregnancy in apulia region, southern italy 87
Emerging and Re-emerging Arboviral Diseases as a Global Health Problem 83
Tecnologie per l'analisi del proteoma 78
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019? 77
Measles Susceptibility in Apulia: The Italian Mirror? 73
Sorveglianza virologica della nuova variante del virus influenzale A/H1N1 nell’Area Vasta Toscana sud 71
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy 67
Trend della prevalenza di sovrappeso e obesità nei bambini toscani in età scolare dal 2002 al 2016 [Trends of overweight and obesity prevalence among schoolchildren in Tuscany Region (Central Italy), period 2002-2016] 67
Serum neutralizing activity against b.1.1.7, b.1.351, and p.1 sars-cov-2 variants of concern in hospitalized covid-19 patients 66
Seroprevalence of hepatitis e virus in forestry workers from trentino-alto adige region (Northern Italy) 65
Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage 63
SARS-CoV-2 epidemiological trend before vaccination era: a seroprevalence study in Apulia, Southern Italy, in 2020 52
Trend of Correlations between Psychological Symptoms and Socioeconomic Inequalities among Italian Adolescents: Cross-Sectional Study from 2006 to 2018 in Tuscany Region 51
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations 48
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infection 46
Seroprevalence study of Toscana virus and viruses belonging to the Sandfly fever Naples antigenic complex in central and southern Italy 43
Detection of IgM, IgG and SARS-CoV-2 RNA among the personnel of the University of Milan, March through May 2020: The UNICORN study 40
Establishment and validation of a high-throughput micro-neutralization assay for respiratory syncytial virus (subtypes A and B) 39
Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004 37
Measles immunity over two decades in two large Italian Regions: How far is the elimination goal? 34
West Nile Virus Seroprevalence in the Italian Tuscany Region from 2016 to 2019 33
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection 32
COVID-19 Outbreak and BNT162b2 mRNA Vaccination Coverage in a Correctional Facility during Circulation of the SARS-CoV-2 Omicron BA.1 Variant in Italy 32
Immunogenicity of Calvenza-03 EIV/EHV® Vaccine in Horses: Comparative In Vivo Study 31
The burden of influenza and the role of influenza vaccination in adults aged 50-64 years: A summary of available evidence 31
SARS-CoV-2 and influenza virus coinfections in the Tuscan population during the 2021/2022 influenza season 29
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples 28
In vitro virucidal activity of mouthwashes on SARS-CoV-2 27
There is a correlation between nutritional status, Self-Rated Health and Life Satisfaction? Evidence from 2018 Health Behaviour in School-aged Children cross sectional study in a sample of Italian adolescents living in Tuscany Region 26
Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal Vaccines 26
Evaluation of immune response to SARS-CoV-2 Omicron sublineages six months after different vaccination regimens in Italy 26
Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study 25
Improving the ONE HEALTH approach: a lesson from SARS-CoV-2 pandemic 25
Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study 24
An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study 24
Immunogenicity and safety of COVID-19 booster vaccination: A population-based clinical trial to identify the best vaccination strategy 23
Assessment of Pertussis Underreporting in Italy 23
Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy) 23
Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study 21
Virucidal activity in vitro of mouthwashes against a feline coronavirus type II 20
Serological Evidence for Circulation of Influenza D Virus in the Ovine Population in Italy 20
Detection of Influenza D Antibodies in Dogs, Apulia Region, Italy, 2016 and 2023 19
Viricide activity of antimicrobial blue light (405 nm) against the SARS-CoV-2 and influenza virus 18
Virucidal Activity of Lemon Essential Oil against Feline Calicivirus Used as Surrogate for Norovirus 18
Evaluation of antibody response to SARS-CoV-2 variants after 2 doses of mRNA COVID-19 vaccine in a correctional facility 17
Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination 16
Centenarians, semi and supercentenarians, COVID-19 and Spanish flu: a serological assessment to gain insight into the resilience of older centenarians to COVID-19 16
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees 16
Effects of Influenza Vaccine on the Immune Responses to SARS-CoV-2 Vaccination 15
Editorial: Novel approaches to prevention, diagnosis, and treatment of bacterial and viral infections of clinical relevance 15
Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines 14
Prevalence of Influenza B/Yamagata Viruses From Season 2012/2013 to 2021/2022 in Italy as an Indication of a Potential Lineage Extinction 14
Serological follow-up of SARS-CoV-2 asymptomatic subjects 14
The baculovirus expression vector system: a modern technology for the future of influenza vaccine manufacturing 13
Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study 11
In Vitro Antiviral and Virucidal Activity of Ozone against Feline Calicivirus 11
Flu vaccine administration in the period before SARS-CoV-2 infection and its outcomes: An umbrella review 11
Totale 9.762
Categoria #
all - tutte 33.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.141


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.081 0 0 0 0 0 0 166 207 200 181 151 176
2020/20212.442 131 172 105 272 269 249 129 238 162 299 172 244
2021/20221.116 135 177 143 98 49 35 52 37 61 78 95 156
2022/20231.154 67 144 137 144 100 207 44 101 123 32 33 22
2023/20241.134 36 42 90 45 42 251 437 21 13 53 15 89
2024/20251.397 62 227 301 218 366 223 0 0 0 0 0 0
Totale 9.796